Haverhill, MA, United States of America

Shawn ER Schiller

This inventor holds 3 USPTO granted patents and 7 EPO patents. Top assignee: Foghorn Therapeutics Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shawn ER Schiller. Retrieved from https://idiyas.com/inventor/shawn-er-schiller-a6xgrrc1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shawn ER Schiller: Innovator in BAF Complex-Related Disorders

Introduction

Shawn ER Schiller is a notable inventor based in Haverhill, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment of BAF complex-related disorders. His innovative work has led to the development of valuable compounds that hold promise for therapeutic applications.

Latest Patents

Shawn holds 1 patent for his invention titled "Compounds and uses thereof." This patent features compounds and methods that are useful for the treatment of disorders related to the BAF complex. His research in this area is crucial for advancing medical treatments and improving patient outcomes.

Career Highlights

Shawn is currently employed at Foghorn Therapeutics Inc., where he continues to push the boundaries of scientific research. His work at the company focuses on developing innovative solutions for complex medical challenges. His dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Shawn collaborates with talented individuals such as Matthew Netherton and Jing Deng. These partnerships enhance the research efforts at Foghorn Therapeutics Inc. and contribute to the advancement of their projects.

Conclusion

Shawn ER Schiller is a prominent inventor whose work in the treatment of BAF complex-related disorders is paving the way for new therapeutic options. His contributions to the field are invaluable and reflect his commitment to innovation in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…